GUIDED THERAPEUTICS INC issued 4,825,000 shares of common stock to holders of Eligible Warrants.
“on March 2, 2026, the Company issued an aggregate of 4,825,000 shares of Common Stock to holders of Eligible Warrants.”
GUIDED THERAPEUTICS INC — fact timeline
Source-grounded facts extracted from GUIDED THERAPEUTICS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Alan Grujic was appointed as Director at GUIDED THERAPEUTICS INC.
“the Board appointed Mr. Alan Grujic to replace Mr. Cartwright on the Board, effective March 8, 2023.”
Mark Faupel was appointed as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.
“the Board appointed Dr. Mark Faupel, Ph.D., 67, the Company’s Chief Operating Officer since December 2016, to replace Mr. Cartwright as the Company’s President and Chief Executive Officer, effective as of March 6, 2023.”
Gene Cartwright retired as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.
“Dr. Gene Cartwright notified the Board of Directors (the “ Board ”) of Guided Therapeutics, Inc. (the “ Company ”) of his intent to retire from his position as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.